NSC |
Compound |
Enrichment |
Correlation |
NSC 733654 |
6-(3-Chloropropyl)-5,6-dihydro-9-methoxy-3-nitro-5,11-dioxo- 11H-indeno[1,2-c]isoquinoline |
0.0133986477026051 |
-0.040767204 |
NSC 109154 |
Null |
0.0139289274573436 |
-0.30846558 |
NSC 618857 |
4-Piperidinone, 3,5-bis[[(4-methylthio)phenyl]methylene]-, hydrochloride |
0.0139289274573436 |
0.53102971 |
NSC 627371 |
2,1,3-Benzoselanadiazole, nitro-6-(trifluoromethyl)- |
0.0139289274573436 |
-0.35740467 |
NSC 629738 |
1-Naphthalenecarboxamide, N,N'-1,8-(octanediyl)bis- |
0.0139289274573436 |
0.63818663 |
NSC 639505 |
Cyclopentanone, 2-[(4-morpholinyl)methyl]-5-nonylidene, hydrochloride |
0.0139289274573436 |
-0.194196 |
NSC 680553 |
2-Quinoxalinecarboxylic acid, 3-[(4-fluorophenyl)amino]-, ethyl ester |
0.0139289274573436 |
0.67910757 |
NSC 681271 |
1,3,6-Triphenyl-oxazolo(5,4-d)pyrimidin-2',4(1H,3H)-dion |
0.0139289274573436 |
0.34512149 |
NSC 716545 |
Spiro[5.5]undecan-3-ol, 2,8-dibromo-9-chloro-1,1,9-trimethyl-5-methylene-, (2R,3S,6R,8R,9R)- (9CI) |
0.0139289274573438 |
-0.16310459 |
NSC 174121 |
Methotrexate Derivative |
0.0145667015252499 |
-0.39188589 |